This is an excerpt from the May 6, 2021 edition of Medically Necessary, a health care supply chain newsletter. Subscribe here.
The decision: On Wednesday, U.S. Trade Representative Katherine Tai announced that the Biden administration supports waiving intellectual property rights for COVID-19 vaccines.
“This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,” Tai said, according to a statement.
U.S. support doesn’t...